- Cyclo(RADfK)
-
- $58.00
-
2026-07-15
- CAS:756500-23-9
- Purity: 100.00%
- Supply Ability: 10g
|
| | cyclo (Arg-Ala-Asp-d-Phe-Lys) Basic information |
| Product Name: | cyclo (Arg-Ala-Asp-d-Phe-Lys) | | Synonyms: | cyclo (Arg-Ala-Asp-d-Phe-Lys);c(RADfK);Cyclo(-Arg-Ala-Asp-D-Phe-Lys) trifluoroacetate salt;CYCLO(RADFK), BR;Cyclo(RADfK),c(RADfK), BR;Cyclo(L-alanyl-L-α-aspartyl-D-phenylalanyl-L-lysyl-L-arginyl);2-((2S,5R,8S,11S,14S)-8-(4-aminobutyl)-5-benzyl-11-(3-guanidinopropyl)-14-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)aceticacid;Cyclo(RADfK),Inhibitor,inhibit,Integrin | | CAS: | 756500-23-9 | | MF: | C28H43N9O7 | | MW: | 617.71 | | EINECS: | | | Product Categories: | | | Mol File: | 756500-23-9.mol |  |
| | cyclo (Arg-Ala-Asp-d-Phe-Lys) Chemical Properties |
| density | 1.45±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | pka | 4.01±0.10(Predicted) | | form | Solid | | color | White to off-white | | Water Solubility | Water : ≥ 25 mg/mL (40.47 mM) | | Sequence | Cyclo(Arg-Ala-Asp-d-Phe-Lys) | | InChIKey | SMFHXHGBDFBWOX-OVACWLFONA-N | | SMILES | C(C1C=CC=CC=1)[C@H]1NC([C@@]([H])(NC([C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC1=O)C)=O)CC(=O)O)=O |&1:7,10,14,18,29,r| |
| | cyclo (Arg-Ala-Asp-d-Phe-Lys) Usage And Synthesis |
| Uses | Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis. | | References | [1] Srivatsan A, et al. Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics withenhanced tumor-imaging and photosensitizing (PDT) efficacy. Mol Pharm. 2011 Aug 1;8(4):1186-1197. DOI:10.1021/mp200018y |
| | cyclo (Arg-Ala-Asp-d-Phe-Lys) Preparation Products And Raw materials |
|